AI-generated summary
In this randomized trial of 66 patients with primary Sjögren's syndrome and dry mouth, the authors report that low-level laser therapy at 808 nm did not improve xerostomia or salivary flow compared with placebo. Neither group showed significant changes in symptom scores, salivary flow, or salivary biomarkers, and the authors conclude the protocol produced no improvement.
- Participants
- 66
- Who or what was studied
- Patients with dry mouth symptoms associated with primary Sjögren's syndrome receiving care at a university hospital
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The abstract does not describe limitations beyond the single-site setting and the specific protocol tested, so generalizability to other laser protocols is unclear.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
- Energy density (fluence)
- 4.0 J/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.